Literature DB >> 2105327

Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge.

M Lauritzen1, A J Hansen, D Kronborg, T Wieloch.   

Abstract

The present study aimed to study the relation between the release of arachidonic acid (AA) and the energy state in cerebral cortices of rats during single episodes of cortical spreading depression (CSD). The changes in concentrations of AA, labile phosphate compounds [ATP, ADP, AMP, and phosphocreatine (PCr)], and glycolytic metabolites (lactate, pyruvate, glucose, and glycogen) were studied during and following the large change of the local direct current (DC) potential. Free AA increased markedly during the DC shift, continued to increase during the subsequent 3 min, and returned to control levels at 4-5 min after CSD. PCr decreased by 38% in the first minutes following the DC shift, while ADP increased by 38%. Both returned to normal within a few minutes. ATP, AMP, and energy charge remained constant throughout the experimental period. Glucose decreased by 47% and glycogen by 34% for a few minutes following CSD, while lactate increased by 105% at 2-3 min and by 77% at 4-5 min after CSD. The metabolites returned to control levels at 10 min after CSD. Considering the constant energy charge at all time points during CSD, it is suggested that the AA rise reflects augmented phospholipase activity due to either increased intracellular [Ca2+] or receptor stimulation or both. The possibility that N-methyl-D-aspartate receptors play a role in the release of AA, and that free AA in turn could be part of the mechanism of CSD, is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105327     DOI: 10.1038/jcbfm.1990.14

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  17 in total

Review 1.  Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.

Authors:  Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

2.  Unilateral cortical spreading depression affects sleep need and induces molecular and electrophysiological signs of synaptic potentiation in vivo.

Authors:  Ugo Faraguna; Aaron Nelson; Vladyslav V Vyazovskiy; Chiara Cirelli; Giulio Tononi
Journal:  Cereb Cortex       Date:  2010-03-26       Impact factor: 5.357

Review 3.  Chaos and commotion in the wake of cortical spreading depression and spreading depolarizations.

Authors:  Daniela Pietrobon; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2014-06       Impact factor: 34.870

4.  Spreading depolarization and neuronal damage or survival in mouse neocortical brain slices immediately and 12 hours following middle cerebral artery occlusion.

Authors:  Dylan Petrin; Peter J Gagolewicz; Rasha H Mehder; Brian M Bennett; Albert Y Jin; R David Andrew
Journal:  J Neurophysiol       Date:  2019-02-27       Impact factor: 2.714

Review 5.  Spreading Depression, Spreading Depolarizations, and the Cerebral Vasculature.

Authors:  Cenk Ayata; Martin Lauritzen
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

6.  Differential contribution of COX-1 and COX-2 derived prostanoids to cortical spreading depression-Evoked cerebral oligemia.

Authors:  Helaine Gariepy; Jun Zhao; Dan Levy
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

7.  Cyclosporine A, FK506, and NIM811 ameliorate prolonged CBF reduction and impaired neurovascular coupling after cortical spreading depression.

Authors:  Henning Piilgaard; Brent M Witgen; Peter Rasmussen; Martin Lauritzen
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-23       Impact factor: 6.200

8.  Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms.

Authors:  M A Moskowitz; K Nozaki; R P Kraig
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

Review 9.  Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression.

Authors:  David W Busija; Ferenc Bari; Ferenc Domoki; Takashi Horiguchi; Katsuyoshi Shimizu
Journal:  Prog Neurobiol       Date:  2008-09-12       Impact factor: 11.685

10.  Effects of Ca2+ channel blockers on cortical hypoperfusion and expression of c-Fos-like immunoreactivity after cortical spreading depression in rats.

Authors:  M Shimazawa; H Hara; T Watano; T Sukamoto
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.